recombinant erythropoietin biosimilar (Megalabs)

N/A

Report date: 2025/03/19 11:42:59

Base Information

Drug Namerecombinant erythropoietin biosimilar (Megalabs)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Biosimilar

Mechanisms of ActionErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUruguay

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMegalabs

China Registration ClassN/A

Active CompaniesMegalabs

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A